Shares of EXACT Sciences Corporation (NASDAQ:EXAS), declined – 0.88% to $18.06, amid its last exchanging session. Exact Sciences Corp. (EXAS) proclaimed that the Centers for Medicare and Medicaid Services (CMS) issued a preparatory determination keeping up the present repayment rate for Cologuard, the organization’s non-obtrusive, stool DNA-based colon disease screening test.

CMS considered repayment for another CPT charging code for Cologuard (81528), notwithstanding a solicitation for reexamination of Cologuard’s present repayment rate. In its determination, CMS affirmed a crosswalk of the new CPT code for Cologuard to three existing codes, which yield a present repayment rate of $492.72. The new CPT code replaces the G code allocated to Cologuard as a component of CMS’ national scope determination from October, 2014.

Precise Sciences Corporation, a sub-atomic diagnostics organization, concentrates on growing non-obtrusive colorectal tumor screening items. The organization adds to the Cologuard, a non-obtrusive stool-based DNA colorectal disease screening test that is intended to identify pre-destructive injuries or polyps, and each of the four phases of colorectal growth.

Shares of Newcastle Investment Corp. (NYSE:NCT), declined – 4.60% to $4.15, amid its last exchanging session.

Newcastle Investment Corp. works as a land speculation trust (REIT) in the United States. The organization puts resources into and oversees land related and different speculations, numbering senior lodging properties; obligation ventures financed with collateralized obligation commitments; other obligation speculations; and interests in fairways and offices.

Newcastle Investment Corp. (NCT) announced that its Board of Directors has proclaimed a money profit on its basic load of $0.12 per offer for the quarter finishing September 30, 2015. The profit is payable on October 30, 2015 to shareholders of record on October 1, 2015.

The Board of Directors likewise announced profits on the Company’s favored stock for the period beginning August 1, 2015 and finishing October 31, 2015. The profits are payable on October 30, 2015 to shareholders of record on October 1, 2015. The Company will pay profits of $0.609375, $0.503125 and $0.523438 per offer on the 9.750% Series B, 8.050% Series C and 8.375% Series D favored stock, individually.

Notes to the Stakeholders:

This article is the intellectual property of The purpose of penning down this article has been just to share information. Moreover, it is firmly believed that all the information that are revealed in this article are from reliable sources, however, we do not make any representations or warranties whatsoever of any kind, express or implied, as far as the completeness, accurateness, or reliability with respect to this article is concerned.

All the respectable visitors to this website are kindly advised to conduct their own independent research into individual stocks prior to making a purchase decision.

This article contains an advanced information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as well as statements regarding the forseeable frequent growth of the market for the corporation’s products, the corporation’s capability to fund its capital requirement in the close-to term and in the long term; pricing pressures; etc.

Furthermore, any statement that expresses or involves discussions with respect to forecast, expectations, beliefs, strategy, projection, objectives, aims, assumption, or future events or performance may be forward looking statements. In addition, the forward-looking statements are wholly and solely based upon expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. An easy way to identify the forward looking statements is through the use of such words as be expecting, will, foresee, guess, considered, or by statements that indicates certain actions may, could, should/might occur.


Please enter your comment!
Please enter your name here